Jackson ImmunoResearch Laboratories

Executive Summary

Jackson ImmunoResearch Laboratories, founded in 1982 and headquartered in Ely, UK, is a leading manufacturer of high-quality secondary antibodies and conjugates for the global life sciences research market. The company's products are essential for techniques such as Western blotting, immunohistochemistry, flow cytometry, and ELISA, serving academic, pharmaceutical, and biotechnology laboratories worldwide. With over four decades of experience, Jackson ImmunoResearch has built a reputation for reliability, specificity, and consistency, making it a trusted supplier in the antibody reagents space. The privately held company continues to innovate, offering a broad portfolio of over 3,000 products including enzyme-conjugated, fluorochrome-conjugated, and biotinylated antibodies, as well as specialty formats like F(ab')2 fragments and pre-adsorbed antibodies for minimizing cross-reactivity. As research funding and biomedical R&D spending grow globally, Jackson ImmunoResearch is well-positioned to benefit from the steady demand for essential research tools.

Upcoming Catalysts (preview)

• Q4 2026Launch of Recombinant Secondary Antibodies70% success
• Q2 2027Expansion into Asian Markets (e.g., China, Japan)60% success
• Q1 2027Strategic Partnership or Distribution Agreement with Major Life Science Supplier50% success